$29.59
-0.12-0.4%
最終更新: Oct 5, 4:00 PM
$29.59
-0.12-0.4%
Benzinga
Benzinga
Benzinga
月曜日, 10 05
Benzinga
© 2026 Benzinga | All Rights Reserved
Immunocore Holdings (IMCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.02 | $-0.26 | $-0.23 | $-0.26 |
| Actual | $-0.02 | $0.25 | $-0.60 | $0.00 |
| Surprise | -200.0% | +196.2% | -160.9% | +100.0% |
| Revenue | ||||
| Estimate | $111.0M | $107.4M | $107.8M | $101.1M |
| Actual | $115.9M | $106.7M | $104.5M | $103.7M |
| Surprise | +4.40% | -0.69% | -3.08% | +2.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.12 | $-0.17 | $0.06 | $0.14 |
| Revenue | ||||
| Consensus | $113.1M | $116.7M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.02 | $0.02 | -200.0 % |
| Q1 | May 6, 2026 | $0.25 | $-0.26 | 196.2 % |
| Q4 | Feb 25, 2026 | $-0.60 | $-0.23 | -160.9 % |
| Q3 | Nov 6, 2025 | $0 | $-0.26 | 100.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $115.93M | $111.04M | 4.40 % |
| Q1 | May 6, 2026 | $106.68M | $107.42M | -0.69 % |
| Q4 | Feb 25, 2026 | $104.48M | $107.79M | -3.08 % |
| Q3 | Nov 6, 2025 | $103.69M | $101.06M | 2.61 % |